aminopterin has been researched along with Disease Models, Animal in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Clausen, MH; Peiró CadahÃa, J; Petrovic, K; Previtali, V; Troelsen, NS | 1 |
Caldana, E; Cassani, B; Castelli, A; Ficara, F; Menale, C; Muggeo, S; Paulis, M; Recordati, C; Scanziani, E; Strina, D; Susani, L; Vezzoni, P; Villa, A | 1 |
Amengual, JE; Bates, SE; Bhagat, G; Cremers, S; Deng, C; Jain, S; Jirau-Serrano, X; Karan, C; O'Connor, OA; Olive, KP; Palermo, CF; Realubit, R; Sastra, SA; Scotto, L; Thomas, T; Wei, Y; Zhang, Y; Zullo, KM | 1 |
Ishih, A; Kino, H; Muregi, FW | 1 |
Marchi, E; O'Connor, OA; Paoluzzi, L; Scotto, L; Seshan, VE; Zain, JM; Zinzani, PL | 1 |
Gardner, J; Gonen, M; Heaney, M; O'Connor, OA; Sirotnak, F; Smith, EA; Teruya-Feldstein, J; Toner, LE; Vrhovac, R | 1 |
Chernoff, GF; Jones, KL | 1 |
Baggott, JE; Freeberg, LE; Gay, RE; Gay, S; Gopal Nair, M; Hudson, BB; Koopman, WJ; Krumdieck, CL; Morgan, SL; Vaughn, WH | 1 |
Schwartz, E | 1 |
1 review(s) available for aminopterin and Disease Models, Animal
Article | Year |
---|---|
Drugs and chemicals associated with intrauterine growth deficiency.
Topics: Abnormalities, Drug-Induced; Adult; Aminopterin; Animals; Disease Models, Animal; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Fetal Growth Retardation; Heroin Dependence; Humans; Infant, Low Birth Weight; Infant, Newborn; Methadone; Mice; Phenytoin; Pregnancy; Rats; Smoking | 1978 |
8 other study(ies) available for aminopterin and Disease Models, Animal
Article | Year |
---|---|
Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis.
Topics: Aminopterin; Animals; Antirheumatic Agents; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrogen Peroxide; Injections, Intraperitoneal; Methotrexate; Molecular Structure; Prodrugs; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2020 |
Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.
Topics: Aminopterin; Animals; Base Sequence; Cell Differentiation; Chromosomes, Mammalian; Clone Cells; CRISPR-Cas Systems; Culture Media; Disease Models, Animal; Gene Editing; Genetic Therapy; Granulocytes; Granulomatous Disease, Chronic; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Induced Pluripotent Stem Cells; Male; Mice; NADPH Oxidase 2; Proof of Concept Study; Sequence Deletion; Thioguanine; Thymidine; X Chromosome | 2019 |
Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma.
Topics: Aminopterin; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Depsipeptides; Disease Models, Animal; Drug Synergism; Flow Cytometry; Humans; Luminescent Measurements; Lymphoma, T-Cell; Mice; Transfection; Xenograft Model Antitumor Assays | 2015 |
Plasmodium berghei: lack of antimalarial activity of an analogue of folate precursor, 2,4-diamino-6-hydroxymethylpteridine in a mouse model.
Topics: Aminopterin; Animals; Antimalarials; Disease Models, Animal; Folic Acid Antagonists; Malaria; Male; Methotrexate; Mice; Mice, Inbred ICR; Parasitemia; Plasmodium berghei; Pteridines; Random Allocation | 2008 |
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.
Topics: Aminopterin; Animals; Apoptosis; Boronic Acids; Bortezomib; Caspase 8; Caspase 9; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lymphoma, T-Cell; Mice; Mice, SCID; Neoplasm Transplantation; Pyrazines; Xenograft Model Antitumor Assays | 2010 |
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.
Topics: Aminopterin; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Gemcitabine; Humans; In Vitro Techniques; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, SCID; Time Factors; Xenograft Model Antitumor Assays | 2006 |
Long-term treatment of the MRL/lpr mouse with methotrexate and 10-deazaaminopterin.
Topics: Aminopterin; Animals; Autoimmune Diseases; Blood Urea Nitrogen; Dermatitis; Disease Models, Animal; Female; Joints; Lymph Nodes; Methotrexate; Mice; Proteinuria | 1992 |
[Effect of aminopterin (folic acid antagonist) on the course of experimental tuberculosis in guinea pigs].
Topics: Aminopterin; Animals; Disease Models, Animal; Guinea Pigs; Mycobacterium tuberculosis; Streptomycin; Tuberculosis | 1973 |